Related Experiment Video
Updated: Jun 14, 2025

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
[Secondary hypertension: diagnosis and treatment]
Paolo Verdecchia1, Gianpaolo Reboldi2, Giovanni Mazzotta3
1Fondazione Umbra Cuore e Ipertensione-ONLUS, Perugia - S.C. Cardiologia, Ospedale S. Maria della Misericordia, Perugia.
Insights
Secondary hypertension, often overlooked, affects 5-10% of patients and is more common in difficult-to-control cases. Suspect secondary causes in young patients, those with resistant hypertension, or specific clinical signs.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Essential hypertension lacks clear causes in most patients.
- Secondary hypertension, due to identifiable causes, is found in 5-10% of hypertensive individuals, rising to over 20% in resistant cases.
- Recognizing secondary hypertension is crucial for effective management.
Purpose of the Study:
- To review the causes, prevalence, and diagnostic clues of secondary hypertension.
- To highlight specific conditions associated with secondary hypertension across different age groups.
- To provide guidance on when to suspect and investigate secondary hypertension.
Main Methods:
- Literature review of secondary hypertension causes and prevalence.
- Analysis of clinical characteristics and diagnostic indicators.
- Categorization of causes by age group (children, adults, elderly).
Main Results:
- Secondary hypertension prevalence increases significantly in treatment-resistant cases.
- Common causes vary by age: aortic conditions in children; renal artery stenosis, primary hyperaldosteronism, Cushing's in adults.
- Parenchymal nephropathy and hyperparathyroidism occur at all ages; pheochromocytoma/paraganglioma in younger adults.
- Key suspicion indicators include early onset (<30 years), treatment resistance, severe or rapidly worsening hypertension, endocrine signs, non-dipping BP, and sleep apnea.
Conclusions:
- Secondary hypertension is a significant contributor to difficult-to-control blood pressure.
- A high index of suspicion and targeted investigation are necessary for diagnosis.
- Identifying and treating secondary causes can lead to improved hypertension management and outcomes.
Abstract:
Hypertension does not recognize obvious pathogenic causes in the majority of patients (essential hypertension). However, a secondary underlying cause of hypertension can be recognized in 5-10% of unselected hypertensive patients, and this prevalence may increase to more than 20% in patients with hypertension that is difficult to control or frankly resistant to treatment. In children, secondary hypertension is most often due to aortic coarctation, distal thoracic or abdominal aortic stenosis, or specific gene mutations. In adults or elderly individuals, secondary hypertension is most often due to atherosclerotic renal artery stenosis, primary hyperaldosteronism, and Cushing's disease or syndrome. Parenchymal nephropathy and hyperparathyroidism can cause hypertension at all ages, while pheochromocytoma and paraganglioma tend to occur more often in adolescents or young adults. In general, secondary hypertension should be suspected in subjects with: (a) onset of hypertension under 30 years of age especially if in the absence of hypertensive family history or other risk factors for hypertension; (b) treatment-resistant hypertension; c) severe hypertension (>180/110 mmHg), malignancy, or hypertensive emergencies; d) rapid rise in blood pressure values in previously well controlled patients. Any clinical signs suspicious or suggestive of hypertension from endocrine causes, a "reverse dipping" or "non-dipping'" profile at 24 h ambulatory blood pressure monitoring not justified by other factors, signs of obvious organ damage may be helpful clues for diagnosis. Finally, patients snoring or with clear sleep apnea should also be considered for possible secondary hypertension.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

